Roivant officer plans sale of 5,112 shares
Roivant Sciences officer Meghan Fitzgerald filed a Rule 144 notice for a planned sale of 5,112 ROIV common shares, with prior 10b5-1 sales also disclosed.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Roivant Sciences Ltd. (ROIV) received a notice under Rule 144 that officer Meghan Fitzgerald plans to sell 5,112 shares of common stock, held at Morgan Stanley Smith Barney LLC Executive Financial Services. The shares relate to Restricted Stock Units from the issuer dated September 10, 2026.
The notice also lists prior Rule 10b5-1 sales of 20,000 shares for $798,010.00 on September 8, 2026 and 10,000 shares for $349,000.00 on June 30, 2026.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Units financial
10b5-1 Sales regulatory
Form 144 regulatory
Common stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filing disclose for Roivant Sciences Ltd. (ROIV)?
What prior sales by Meghan Fitzgerald in ROIV stock are reported in the past three months?
What trading plan is referenced in Meghan Fitzgerald’s ROIV Form 144 activity?
On which market is the ROIV stock in this Form 144 listed?
AI-generated analysis. How Rhea-AI works. Not financial advice.